Ofra Maimon
Impact in
-
- Neuroendocrine Tumor Research Advances
-
- Adrenal and Paraganglionic Tumors
Papers in
-
- Breast Cancer Treatment Studies 7
- Cancer, Hypoxia, and Metabolism 1
-
- Neuroendocrine Tumor Research Advances 7
- Co-authors
- Amichay Meirovitz (12 shared papers)Simona Grozinsky‐Glasberg (9 shared papers)Grace Kong (2 shared papers)Rodney J. Hicks (2 shared papers)Prof Michael S. Hofman (2 shared papers)David A. Pattison (1 shared paper)Jason Callahan (1 shared paper)Tamar Peretz (14 shared papers)
- Journals
- Anticancer Research (3 papers)Frontiers in Oncology (2 papers)Neuroendocrinology (2 papers)Medical Oncology (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Ofra Maimon
25 papers receiving 347 citations
Peers
Comparison fields: 5 of 42
- Epidemiology 145
- Surgery 102
- Cancer Research 29
- Radiology, Nuclear Medicine and Imaging 43
- Health Informatics 3
Countries citing papers authored by Ofra Maimon
This map shows the geographic impact of Ofra Maimon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ofra Maimon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ofra Maimon more than expected).
Fields of papers citing papers by Ofra Maimon
This network shows the impact of papers produced by Ofra Maimon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ofra Maimon. The network helps show where Ofra Maimon may publish in the future.
Co-authors
The 25 scholars most cited alongside Ofra Maimon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 136 | |
| 2 | 2019 | 56 | |
| 3 | 2018 | 22 | |
| 4 | 2024 | 14 | |
| 5 | 2013 | 12 | |
| 6 | 2020 | 11 | |
| 7 | The prognostic significance of LIAISON(R) CA15-3 assay in primary breast cancer. | 2013 | 10 |
| 8 | 2023 | 10 | |
| 9 | 2020 | 9 | |
| 10 | 2022 | 9 | |
| 11 | 2021 | 8 | |
| 12 | 2023 | 8 | |
| 13 | 2021 | 7 | |
| 14 | 2022 | 7 | |
| 15 | 2024 | 7 | |
| 16 | 2020 | 6 | |
| 17 | 2019 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2022 | 2 | |
| 20 | 2022 | 2 |
About Ofra Maimon
Ofra Maimon is a scholar working on Cancer Research, Epidemiology, Oncology, Genetics and Immunology, having authored 26 papers that have together received 351 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (7 papers), Breast Cancer Treatment Studies (7 papers), Adrenal and Paraganglionic Tumors (2 papers), BRCA gene mutations in cancer (2 papers), Cancer Risks and Factors (2 papers), Cancer, Hypoxia, and Metabolism (1 paper), Artificial Intelligence in Healthcare and Education (1 paper) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Epidemiology (145 citations), Surgery (102 citations), Cancer Research (29 citations), Radiology, Nuclear Medicine and Imaging (43 citations) and Health Informatics (3 citations). Ofra Maimon has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Amichay Meirovitz, Simona Grozinsky‐Glasberg, Grace Kong, Rodney J. Hicks, Prof Michael S. Hofman, David A. Pattison, Jason Callahan, Tamar Peretz, Luna Kadouri and Benjamin Nisman. Their work appears in journals such as Anticancer Research, Frontiers in Oncology, Neuroendocrinology, Medical Oncology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.